# US 2002/0177722 A1 · Method for the preparation of citalopram

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0177722 A1
- Document ID: US20020177722A1
- Status: Published application
- Kind: A1
- Application number: 10/138,811
- Filed: 2002-05-03
- Published: 2002-11-28
- Earliest claimed: 1999-10-25
- Assignees: H. Lundbeck A/S
- Inventors: Michael Harold Rock; Hans Petersen; Peter Ellegaard
- Web page: https://patentgrep.com/patent/US20020177722A1

## CPC

- C07D 307/87: Benzo [c] furans; Hydrogenated benzo [c] furans
- A61P 25/24: Antidepressants
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method for the preparation of escitalopram comprising reaction of a compound of 1 wherein R is C1-6 alkyl, acyl, C1-6 alkylsulfonyl or arylsulfonyl, with 3-(N,N-dimethylamino)-propyl magnesium halide, to prepare citalopram.

## Claims

### Claim 1

A method for the preparation of escitalopram, comprising the steps of
a) deprotecting a compound of Formula IV
13
wherein R is C1-6 alkyl, acyl, C1-6 alkylsulfonyl or arylsulfonyl;
b) reacting the resulting compound of Formula VIII
14
with 3-(N,N-dimethylamino)propyl magnesium halide, to prepare the racemic compound of Formula III
15
followed by
c) separation of the R and S enantiomers of the compound of formula III;
d) ring closure of the S-enantiomer of the compound of formula III and isolation of escitalopram or a salt thereof.

### Claim 2 (depends on 1)

The method of claim 1, wherein R is selected from the group consisting of pivaloyl or optionally substituted benzoyl.

### Claim 3 (depends on 1)

The method of claim 1, wherein the R-enantiomer of the compound of formula III obtained in step c) is converted to the compound of formula IV by:
e) protection of the R-enantiomer of the compound of formula III followed by dehydration to form a compound of formula
16
f) oxidative cleavage of the compound of formula VII to form a compound of formula IV;
and thereafter optionally repeating steps a) to f).

### Claim 4 (depends on 3)

The method of claim 3 wherein the oxidative cleavage of the compound of formula VII is effected by oxidation performed by MnO4− (permanganates), ozone, RuCl3 or OsO4.

### Claim 5 (depends on 1)

A method for the preparation of citalopram, comprising the steps of
a) deprotecting a compound of Formula IV
17
wherein R is as defined in claim 1
b) reacting the resulting compound of Formula VIII
18
with 3-(N,N-dimethylamino)propyl magnesium halide, to prepare the racemic compound of formula III
19
followed by ring closure of racemic compound of formula III and isolation of racemic citalopram or a salt thereof.

### Claim 6 (depends on 3, 4, 5)

The method of any of claims 3-5 wherein R is acyl, acetyl or optionally substituted benzoyl.

### Claim 7 (depends on 6)

The method of claim 6, wherein R is acyl.

### Claim 8 (depends on 7)

The method of claim 7, wherein said acyl is pivaloyl.
